Dataset Information


Is Myomectomy Prior to Assisted Reproductive Technology Cost Effective in Women with Intramural Fibroids?

ABSTRACT: AIM:To evaluate the cost effectiveness of surgery to remove intramural (IM) fibroids prior to assisted reproductive technology (ART). METHODS:The decision tree mathematical model along with sensitivity analysis was performed to analyze cost effectiveness of: (1) myomectomy followed by ART or (2) ART with IM myoma(s) in situ. RESULTS:At the median ongoing pregnancy (OP) rate (OPR) reported in the literature for a fresh, autologous ART cycle with IM fibroids in situ vs. post-IM myomectomy, average cost per OP was $72,355 vs. 66,075, indicating a cost savings with myomectomy. Sensitivity analysis over the range of reported OPRs demonstrated that pre-ART IM myomectomy was always cost effective when OPR among women with in situ myomas was <15.4%. However, for OPRs ?15.4%, pre-ART IM myomectomy was only cost effective if it increased OPR by at least 9.6%. At the high end of OPRs reported for patients with IM myomas in situ (31.4%), a 19.5% improvement in OPR was needed to justify IM myomectomy from a cost perspective. CONCLUSION:Myomectomy should be used sparingly in cases where the goal of surgery is to achieve improvement in the outcomes of ART.

SUBMITTER: Ojo-Carons M 

PROVIDER: S-EPMC6261445 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4793163 | BioStudies
2019-01-01 | S-EPMC6463606 | BioStudies
2019-01-01 | S-EPMC6514991 | BioStudies
2019-01-01 | S-EPMC6431064 | BioStudies
2009-01-01 | S-EPMC2688005 | BioStudies
2019-01-01 | S-EPMC6924655 | BioStudies
2014-01-01 | S-EPMC4138422 | BioStudies
2020-01-01 | S-EPMC7600627 | BioStudies
2020-01-01 | S-EPMC7369025 | BioStudies
2020-01-01 | S-EPMC7083063 | BioStudies